|
Download
article
301kb
pdf? |
|
Detection of Dipeptidyl Peptidase Activity with DPPIV-Glo™ Assay
Joseph Alex Davis, Vamshi Krishna Tulasi Abhijit Ray, and Pradip
Bhatnagar, Ranbaxy Laboratories, Ltd. India
Ranbaxy Laboratories Ltd., is a research-based, international
pharmaceutical company located in India. In addition to being a dominant player
in the area of developing generic medicines, Ranbaxy has committed to investing
in drug discovery. Keeping in mind the highly complex, cost-intensive and
failure-prone nature of drug discovery, Ranbaxy has evolved an alliance-centric
business
model to bring sustainability to its drug discovery effort. Ranbaxy has entered
into alliance with partners at different stages of drug discovery and
development. A partnership with Promega is an effort to access robust assays
that can assist Ranbaxy in hit identification and lead optimization during early
drug discovery stages. Here we describe our characterization of the DPPIV-GLO™
Protease Assay.
See information about
Protease Assay Reagents
Reagents from Promega
|
